Fusion Genes
Fusion genes are non-native genes that arise as a result of chromosomal aberrations such as translocations, inversions, and deletions. These genes play an important role in hematology and oncology research as they have been identified as a major driver of tumorigenesis in various cancers. The formation of fusion genes results in the generation of chimeric proteins that possess altered functions. These proteins manifest a dominant oncogenic activity that confer a selective growth advantage to the transformed cell. The expression of fusion genes has been found to be associated with the initiation and progression of several types of cancers including hematological malignancies such as acute lymphoblastic leukemia, chronic myeloid leukemia and lymphoma. The identification of fusion genes has implications for both diagnosis and treatment of cancers. In fact, some fusion genes have been found to be associated with a favorable response to targeted therapies. This has led to the development of several specific inhibitors that show promise in the treatment of patients with tumors harboring particular fusion genes. The detection of fusion genes also allows for the use of molecular diagnostic tests that can accurately identify and monitor the disease. In conclusion, fusion genes are important biomarkers in hematology and oncology research. The identification of these genes not only helps in the diagnosis and treatment of cancers but also offers significant insights into the underlying mechanisms of tumorigenesis. Therefore, further research is warranted to better understand the role of fusion genes in the development, progression and treatment of cancer.
← Hematology Research and Oncology Research